With the rise in demand of bio-pharmaceuticals, greater challenges are now arising with their rapid growth. Even though the cost of bio-pharmaceuticals come at a high price, it has not decreased their growth and profits.
McKinsey
states that biopharmaceuticals account for $163 billion in global revenue, which in turn accounts for 20 percent of the pharmaceutical market.
Cognizant
highlights that while the market is growing increasingly fast in demand, so too is the amount of waste with 20% of products believed to go to waste in the process of transportation.
Bio-pharmaceuticals itself has the potential to become the core of the pharmaceutical industry considering its extensive rapid market growth and high profits. However, it goes without saying that there are several challenges lying ahead for the bio-pharmaceutical industry including efficiency, meeting increasing regulations in the industry and end-to-end visibility.
KELVIN,
a smart IoT asset tracker may just solve all these problems in one, with its capabilities to track the supply chain, reducing bottlenecks in transportation and regulating their transportation. KELVIN has the capability of tracking temperature, light exposure, shock and location. Tracking from A to B at any point in the supply chain is able to become headache and worry free with the help of KELVIN.
Improving efficiency within the supply chain is becoming a prominent challenge as the industry is growing rapidly. The industry at the same time will need to be able to cope with managing increasing inventory, distribution and all aspects of the cold chain coming together. Better managing of the cold chain will enable bio-pharmaceutical companies to reduce waste and improve their efficiency in order to cope with the rapid growth.
Cargosense
has pointed out that 20% of pharmaceuticals are damaged due to malfunction within the cold chain. The percentage will only increase further if bio-pharmaceutical companies are unable to increase their efficiency.
This is becoming more manageable by the new technology that is entering the market. KELVIN is a perfect example of the increasing capability of technology that is entering the market. KELVIN tracks consignments anytime, anywhere never failing you by relaying data in near real-time via our platform, becoming one your most valuable assets giving you a competitive edge over your competitors. KELVIN will never leave you having to second guess the data collected making hand-overs during transport a breeze.
As the industry is rapidly growing, regulations and compliance are becoming more complicated. Bio-pharmaceutical companies may find it difficult to keep up with the rising demands of regulation and compliance companies as the industry is growing so fast. KELVIN makes tracing the supply chain from one end to another easy with its near real-time capabilities.
With the supply chain of bio-pharmaceuticals being so rigid, any such violations can instantly affect the potency of the bio-pharmaceuticals risking the patient’s health and ultimately the reputation of pharmaceutical companies. Such technology does not only benefit companies in countries such as Australia, Europe and even the United States of America but also developing countries. Developing countries have experienced numerous issues with counterfeit drugs.
KELVIN
has the power to eliminate such drugs entering the market with its endless capabilities. Eliminating counterfeit drugs can not only save lives of those in developing countries, but the reputation of pharmaceutical companies and increase endless visibility in the supply chain.
Creating end-to end visibility in cold chain is essential for the bio-pharmaceutical industry to combat challenges of rapid growth in the industry. Emerging IoT technology will allow end-to-end visibility to be developed. With the increasing visibility, this effectively gives stakeholders a better understanding of not only the processes involved in the bio-pharmaceutical industry but also risks involved, distribution, challenges experienced and delivery of the pharmaceuticals. This ultimately leads to higher retention of customers as more trust is built with great visibility in the pharmaceutical process. Greater visibility is created allowing manual labour to be reduced. KELVIN ultimately is able to transform supply chain processes for the cold chain industry via its near real-time data and endless capabilities. With unexpected delays in transportation KELVIN is able to notify concerned parties of the delay and allow these entities to take immediate measures to combat any potential damage and wastage of the bio-pharmaceuticals.
Challenges of the rapid growth that lies ahead for the bio-pharmaceutical industry are greatly amounting. IoT principles may in fact be the answer to tackling the rapid growth in the industry. With stricter regulations constantly being faced by bio-pharmaceutical companies, it’s no wonder the industry is looking towards a solution that can improve the flow of their supply chain. KELVIN ensures visibility at any point of time in your supply chain from beginning to end, ending uncertainty in the supply chain.